PATEL DINESH V PH D

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 16. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 16
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Protagonist Therapeutics, IncPresident and CEOOption exercisenothing paid7,278 sharesSep 10, 2026Protagonist Therapeutics, IncPresident and CEOnothing paidExercise · Sep 10Option exercise7,278Sep 10, 2026
Protagonist Therapeutics, IncPresident and CEOOption exercisenothing paid63,548 sharesSep 10, 2026Protagonist Therapeutics, IncPresident and CEOnothing paidExercise · Sep 10Option exercise63,548Sep 10, 2026
Protagonist Therapeutics, IncPresident and CEOOption exercisenothing paid54,174 sharesSep 10, 2026Protagonist Therapeutics, IncPresident and CEOnothing paidExercise · Sep 10Option exercise54,174Sep 10, 2026
Protagonist Therapeutics, IncPresident and CEOOpen-market sell$1,048,7607,278 sharesSep 10, 2026Protagonist Therapeutics, IncPresident and CEO$1,048,760Sell · Sep 10Open-market sell7,278Sep 10, 2026
Protagonist Therapeutics, IncPresident and CEOOption exercise$157,0597,278 sharesSep 10, 2026Protagonist Therapeutics, IncPresident and CEO$157,059Exercise · Sep 10Option exercise7,278Sep 10, 2026